Literature DB >> 34737536

Virtual Respiratory Urgent Clinics for COVID-19 Symptoms.

Rebecca S Brienza1, Juliette F Spelman1, Kelly Hager1, Christopher Ruser1.   

Abstract

BACKGROUND: The COVID-19 pandemic has forced a shift from in-person to virtual care to reduce exposure risks to patients and health care workers. This report aims to describe a large primary care system's implementation of virtual respiratory urgent care clinics (VRUCs).
METHODS: The VA Connecticut Healthcare System (VACHS) delivers care to more than 58,000 veterans in at 8 primary care sites. VRUCs were established as part of the VACHS primary care rapid transition to virtual care model. Retrospective analysis and qualitative chart reviews were performed from February 2020 through May 2020 to describe characteristics of patients who received care through the VRUCs.
RESULTS: VRUCs were used by > 445 patients, 51% received COVID-19 testing, 10% tested positive, 5% were admitted to the hospital, and 18% had ≥ 1 subsequent emergency department visits. Chart documentation rates of discussion of isolation precautions, high occupational risk, and goals of care were 71%, 25%, and 14%, respectively.
CONCLUSIONS: Average wait time for health care provider evaluation was 104 minutes, suggesting VRUCs are an expedient means to provide assessment of COVID-19 symptoms. Use of templated notes may ensure routine counseling about isolation, occupation, and goals of care.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID: 34737536      PMCID: PMC8562901          DOI: 10.12788/fp.0178

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  10 in total

1.  Utilization of Outpatient Telehealth Services in Parity and Nonparity States 2010-2015.

Authors:  Jillian B Harvey; Shawn Valenta; Kit Simpson; Mark Lyles; James McElligott
Journal:  Telemed J E Health       Date:  2018-05-30       Impact factor: 3.536

Review 2.  State of Telehealth.

Authors:  E Ray Dorsey; Eric J Topol
Journal:  N Engl J Med       Date:  2016-07-14       Impact factor: 91.245

3.  Virtually Perfect? Telemedicine for Covid-19.

Authors:  Judd E Hollander; Brendan G Carr
Journal:  N Engl J Med       Date:  2020-03-11       Impact factor: 91.245

4.  Incorporating telemedicine as part of COVID-19 outbreak response systems.

Authors:  Kimberly Lovett Rockwell; Alexis S Gilroy
Journal:  Am J Manag Care       Date:  2020-04       Impact factor: 2.229

5.  Use of Telehealth to Improve Access to Care at the United States Department of Veterans Affairs During the 2017 Atlantic Hurricane Season.

Authors:  Claudia Der-Martirosian; Karen Chu; Aram Dobalian
Journal:  Disaster Med Public Health Prep       Date:  2020-04-13       Impact factor: 1.385

Review 6.  The Empirical Foundations of Telemedicine Interventions in Primary Care.

Authors:  Rashid L Bashshur; Joel D Howell; Elizabeth A Krupinski; Kathryn M Harms; Noura Bashshur; Charles R Doarn
Journal:  Telemed J E Health       Date:  2016-05       Impact factor: 3.536

7.  Interpreting COVID-19 and Virtual Care Trends: Cohort Study.

Authors:  Saif Khairat; Chenlu Meng; Yuxuan Xu; Barbara Edson; Robert Gianforcaro
Journal:  JMIR Public Health Surveill       Date:  2020-04-15

8.  A Model for Rapid Transition to Virtual Care, VA Connecticut Primary Care Response to COVID-19.

Authors:  Juliette F Spelman; Rebecca Brienza; Robert F Walsh; Paul Drost; Amy R Schwartz; Jeffrey D Kravetz; Patricia Pitkin; Christopher Ruser
Journal:  J Gen Intern Med       Date:  2020-07-23       Impact factor: 5.128

9.  Virtual care expansion in the Veterans Health Administration during the COVID-19 pandemic: clinical services and patient characteristics associated with utilization.

Authors:  Jacqueline M Ferguson; Josephine Jacobs; Maria Yefimova; Liberty Greene; Leonie Heyworth; Donna M Zulman
Journal:  J Am Med Inform Assoc       Date:  2021-03-01       Impact factor: 4.497

10.  Reduced In-Person and Increased Telehealth Outpatient Visits During the COVID-19 Pandemic.

Authors:  Aaron Baum; Peter J Kaboli; Mark D Schwartz
Journal:  Ann Intern Med       Date:  2020-08-10       Impact factor: 25.391

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.